• Explore /
  • Poster
  • / PET-directed combined modality therapy for gastroesophageal junction cancer: First results of the prospective MEMORI trial.

PET-directed combined modality therapy for gastroesophageal junction cancer: First results of the prospective MEMORI trial.

Abstract Poster

Authors

null

Sylvie Lorenzen

Third Department of Internal Medicine (Hematology/Medical Oncology), Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany

Sylvie Lorenzen , Michael Quante , Isabel Rauscher , Julia Slotta-Huspenina , Karl Friedrich Becker , Wilko Weichert , Marcus Feith , Helmut Friess , Stephanie E Combs , Wolfgang Weber , Bernhard Haller , Martin K Angele , Markus Albertsmeier , Christiane Blankenstein , Stefan Kasper , Jens Peter Zimmermann , Hana Algül , Roland M. Schmid , Markus Schwaiger , Jens T Siveke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

2014-000860-16

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4018)

DOI

10.1200/JCO.2019.37.15_suppl.4018

Abstract #

4018

Poster Bd #

123

Abstract Disclosures

Similar Posters

First Author: Hao-Wen Sim

First Author: Jennifer Rachel Eads

First Author: Sarbajit Mukherjee

First Author: Karyn A. Goodman